Dupixent (dupilumab) is a prescription injection that’s used to treat several conditions, including asthma, eczema, and more. It isn’t available in a generic or biosimilar form. Brand-name drugs are ...

Dupixent single-dose prefilled pens feature a hidden needle and single-press auto-injection. The Food and Drug Administration (FDA) has expanded the approval of the Dupixent ® (dupilumab) single-dose ...

* DUPIXENT ® is the only biologic medicine approved by Health Canada to treat moderate-to-severe atopic dermatitis. * Public reimbursement under the Ontario Exceptional Access Program and the New ...

Bullous pemphigoid (BP) is an autoimmune disorder that mainly affects older adults. The condition causes your immune system to attack proteins that hold the layers of your skin together. This damages ...

Dupixent’s dosage can vary based on several factors, including your age, weight, and the condition you’re using it to treat. For example, Dupixent’s dosage for asthma in adults may be different than ...

Common side effects of Dupixent for atopic dermatitis (eczema) include injection site reactions like pain or swelling, eye-related side effects such as pink eye or dry eyes, and increased risk of cold ...

Dupixent (dupilumab), a drug already used to treat atopic dermatitis and asthma, became the first biologic approved for chronic obstructive pulmonary disease (COPD) last fall. Most COPD treatments ...

Approval based on phase 3 data showing significantly more children aged one to 11 years on Dupixent achieved histological disease remission at 16 weeks compared to placebo, which was sustained up to ...